Atorvastatin 10 mg (Tab)

Product Overview

Vaselle – AT is an advanced lipid-regulating formulation containing Atorvastatin 10 mg. As a synthetic HMG-CoA reductase inhibitor, it selectively blocks the microsomal enzyme responsible for converting HMG-CoA to mevalonate in hepatic cholesterol biosynthesis. This intracellular cholesterol depletion upregulates low-density lipoprotein (LDL) cell-surface receptors on hepatocytes, dramatically accelerating the systemic clearance of circulating LDL-C, apolipoprotein B, and triglyceride-rich VLDL particles while elevating high-density lipoprotein (HDL-C) levels.
Designed for everyday cardiovascular protection, this daily pill acts as a cholesterol-lowering solution that halts excess cholesterol production in the liver. By clearing “bad” cholesterol and fats from the bloodstream, it keeps artery walls smooth and open, significantly reducing the risk of heart attacks, strokes, or chest pain.
Developed under stringent quality standards, Vaselle – AT ensures consistent efficacy, safety, and patient compliance — empowering physicians to achieve optimal therapeutic outcomes in Dyslipidemia and Cardiovascular Risk Management.

Powerful LDL and triglyceride reduction with increased HDL levels.
Helps in preventing cardiovascular events and progression of atherosclerosis.
Well-tolerated and suitable for long-term lipid management.
Can be used alone or in combination with antihypertensives or antidiabetic agents.

Each film-coated tablet contains:

Clinically validated for effective cholesterol and triglyceride control.
Reduces risk of stroke, myocardial infarction, and cardiovascular mortality.
Supports comprehensive cardiometabolic care when used in combination regimens.
Offers once-daily dosing with a strong safety and efficacy record.

Part of Yaselle Cardiora – Cardiac & Hypertension Care Division
Protecting every heartbeat with science and care.